Suppr超能文献

软性纤维光学输尿管镜与数字输尿管镜检查术及增强与非增强成像在诊断和治疗上尿路尿路上皮癌(UTUC)中的应用:来自腔内泌尿外科学会临床研究办公室(CROES)-UTUC 注册研究的结果。

Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry.

机构信息

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Department of Urology, Medipol Mega University Hospital, Istanbul Medipol University, Istanbul, Turkey.

出版信息

BJU Int. 2021 Dec;128(6):734-743. doi: 10.1111/bju.15494. Epub 2021 Jun 13.

Abstract

OBJECTIVES

To compare the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) undergoing kidney-sparing surgery (KSS) with fibre-optic (FO) vs digital (D) ureteroscopy (URS). To evaluate the oncological impact of image-enhancement technologies such as narrow-band imaging (NBI) and Image1-S in patients with UTUC.

PATIENTS AND METHODS

The Clinical Research Office of the Endourology Society (CROES)-UTUC registry is an international, multicentre, cohort study prospectively collecting data on patients with UTUC. Patients undergoing flexible FO- or D-URS for diagnostic or diagnostic and treatment purposes were included. Differences between groups in terms of overall survival (OS) and disease-free survival (DFS) were evaluated.

RESULTS

The CROES registry included 2380 patients from 101 centres and 37 countries, of whom 401 patients underwent URS (FO-URS 186 and D-URS 215). FO-URS were performed more frequently for diagnostic purposes, while D-URS was peformed when a combined diagnostic and treatment strategy was planned. Intra- and postoperative complications did not differ between the groups. The 5-year OS and DFS rates were 91.5% and 66.4%, respectively. The mean OS was 42 months for patients receiving FO-URS and 39 months for those undergoing D-URS (P = 0.9); the mean DFS was 28 months in the FO-URS group and 21 months in the D-URS group (P < 0.001). In patients who received URS with treatment purposes, there were no differences in OS (P = 0.9) and DFS (P = 0.7). NBI and Image1-S technologies did not improve OS or DFS over D-URS.

CONCLUSIONS

D-URS did not provide any oncological advantage over FO-URS. Similarly, no differences in terms of OS and DFS were found when image-enhancement technologies were compared to D-URS. These findings underline the importance of surgeon skills and experience, and reinforce the need for the centralisation of UTUC care.

摘要

目的

比较行保留肾单位手术(KSS)的上尿路尿路上皮癌(UTUC)患者接受纤维光学(FO)与数字(D)输尿管镜检查(URS)的肿瘤学结果。评估窄带成像(NBI)和 Image1-S 等图像增强技术在 UTUC 患者中的肿瘤学影响。

患者和方法

欧洲泌尿外科学会(EAU)-UTUC 登记处是一项国际性、多中心的队列研究,前瞻性地收集 UTUC 患者的数据。纳入因诊断或诊断和治疗目的而接受软性 FO 或 D-URS 的患者。评估两组在总生存率(OS)和无病生存率(DFS)方面的差异。

结果

EAU 登记处纳入了来自 101 个中心和 37 个国家的 2380 名患者,其中 401 名患者接受 URS(FO-URS 186 例,D-URS 215 例)。FO-URS 更多地用于诊断目的,而 D-URS 则用于计划联合诊断和治疗策略时。两组的术中及术后并发症无差异。5 年 OS 和 DFS 率分别为 91.5%和 66.4%。接受 FO-URS 的患者平均 OS 为 42 个月,接受 D-URS 的患者平均 OS 为 39 个月(P=0.9);FO-URS 组的平均 DFS 为 28 个月,D-URS 组为 21 个月(P<0.001)。在接受有治疗目的的 URS 的患者中,OS(P=0.9)和 DFS(P=0.7)无差异。与 D-URS 相比,NBI 和 Image1-S 技术并未提高 OS 或 DFS。

结论

D-URS 并未比 FO-URS 提供任何肿瘤学优势。同样,与 D-URS 相比,当比较图像增强技术时,OS 和 DFS 也没有差异。这些发现强调了外科医生技能和经验的重要性,并加强了 UTUC 治疗集中化的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2473/9292011/1f38e76f2a93/BJU-128-734-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验